Heart Research: AI More Accurate Than Technicians Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 28 August 2022 07:00 AM America/Los_Angeles Late-Breaking Heart Research AI More Accurate Than Technicians A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty. Healthcare And AI Concept. Black physician holding virtual heart in open palms with connected poly geometric dots Cedars-Sinai and Smidt Heart Institute Study Presented at European Society of Cardiology Congress 2022 Shows Artificial Intelligence Can Better Assess and Diagnose Cardiac Function In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers. The results, announced today during a late-breaking presentation at the European Society of Cardiology Congress 2022, have immediate translational implications for patients undergoing cardiac function imaging and broader implications for the field of cardiac imaging. “This is the first randomized clinical trial of artificial intelligence in cardiology,” said David Ouyang, MD, a cardiologist in the Department of Cardiology in the Smidt Heart Institute and principal investigator of the study, known as EchoNet-RCT. “With this new knowledge, we hope to improve the quality and effectiveness of echocardiogram imaging for patients everywhere.” Previously, researchers at the Smidt Heart Institute and Stanford University developed one of the first artificial intelligence technologies to assess cardiac function, specifically, left ventricular ejection fraction—the key heart measurement used in diagnosing cardiac function. Their research was published in the prestigious journal Nature. Building on this past research, the most recent study assessed the impact of artificial intelligence in clinical deployment as part of a prospective, blinded and randomized controlled clinical trial. “There has been much excitement about the use of AI in medicine, but the technologies are rarely assessed in prospective clinical trials,” said Ouyang. “This trial was powered to show non-inferiority of the AI compared to sonographer tracings, and so we were pleasantly surprised when the results actually showed superiority for AI with respect to the pre-specified outcomes.” In the study, Cedars-Sinai cardiologists evaluated 3,495 transthoracic echocardiogram studies, comparing initial assessment by artificial intelligence or by a sonographer—also known as an ultrasound technician. One of the major findings was that cardiologists more frequently agreed with the AI initial assessment, such that they corrected only 16.8% of the initial assessments made by AI and simultaneously corrected 27.2% of the initial assessments made by the sonographers. This difference demonstrated not only non-inferiority but actually superiority of AI. The research team also discovered that cardiologists were unable to distinguish between initial assessments made by the AI and sonographers. “We asked our cardiologist over-readers to guess if they thought the tracing they had just reviewed was performed by AI or by a sonographer, and it turns out that they couldn’t tell the difference,” said Ouyang. “This speaks to the strong performance of the AI algorithm as well as the seamless integration into clinical software. We believe these are all good signs for future trial research in the field.” Additionally, the Smidt Heart Institute research team learned that this type of clinical trial can be seamlessly integrated into the standard clinical workflow. “We are excited by the implications of this clinical trial and what it means for the future of artificial intelligence and cardiology,” said Susan Cheng, MD, MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at the Smidt Heart Institute and EchoNet-RCT investigator. “When developed in the right way, artificial intelligence offers the opportunity to improve the quality of echocardiogram readings as well as increase efficiencies in the time and effort spent by busy cardiologists and sonographers alike.” As a next step, Ouyang says the Smidt Heart Institute team plans to evaluate how AI analysis applied to Cedars-Sinai echocardiogram imaging procedures may improve clinical outcomes. Read more from the Cedars-Sinai Blog: Faces of Cedars-Sinai: Dr. Alan Kwan Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories 15 Years of Heart Cedars-Sinai Marks A Decade-and-a-Half Since Founding the Smidt Heart Institute Leading to Breakthroughs in Cardiac Care Surgery and Disease Prevention October 03, 2022 06:01 AM America/Los_Angeles Pioneering heart care is a tradition at Cedars-Sinai. It’s a tradition that took root in 1924, when Cedars-Sinai became home to the first electrocardiogram machine in Los Angeles. The roots grew stronger in the 1970s, when two Cedars-Sinai … Read more From AFib to Fitness Buff A Heart Transformed With the Care and Support of Her Smidt Heart Institute Team Claudia Huerta Went From Being an Overweight Heart Disease Patient to a Heart-Healthy Bodybuilding Competitor September 26, 2022 06:01 AM America/Los_Angeles Claudia Huerta, 43, knows a thing or two about transformations. After being diagnosed with a serious, though common, heart condition called atrial fibrillation (AFib), the payroll manager and Maywood, California, resident transformed herself from … Read more RESEARCH ALERT The New England Journal of Medicine Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement September 17, 2022 08:00 AM America/Los_Angeles FINDINGSA study published today in the New England Journal of Medicine (NEJM) found that among patients with aortic stenosis undergoing transfemoral TAVR, the use of a debris capturing device called cerebral embolic protection reduced the risk of … Read more Show previous items Show next items Contact the Media Team Email: [email protected] Contact Cara Martinez Cara.Martinez@cshs.org Share this release Late-Breaking Heart Research AI More Accurate Than Technicians Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Follow us on Twitter (opens in new window) Visit our Facebook page (opens in new window) (opens in new window) Visit our Youtube profile (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster? Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home